Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the Stocks That Could Mint Millionaires in 2026. Corcept Therapeutics (CORT): Analyst Says Shares Pricing in Growth, New Launch On December 16, UBS analyst Ashwani Verma initiated coverage of Corcept Therapeutics Incorporated (NASDAQ:CORT) stock with a Neutral rating and $95 price target. In an investor note, the analyst cited valuation for the Neutral rating, with the shares up 64% year-to-date. Per the analyst, the stock was already pricing in b ...